Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.295
Abstract: There is a paucity of evidence based therapies for reactive arthritis(ReA). Data is limited for anti-TNF drugs usage [Table 1] with even less data on biosimilars.To find out the outcomes of etanercept biosimilars (ETN-b) use…
read more here.
Keywords:
retrospective case;
reactive arthritis;
etanercept biosimilars;
arthritis ... See more keywords